Boring Money
Pharmeasy had to choose between selling its recent acquisition, Thyrocare, or stifling its investors that have been with it for the last 8 years. It chose the latter. Get full access to Boring Money at boringmoney.in/subscribe [https://boringmoney.in/subscribe?utm_medium=podcast&utm_campaign=CTA_4]
15 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Boring Money-Community!